Yekaterina Chudnovsky
Director/Miembro de la Junta en ELICIO THERAPEUTICS, INC. .
Fortuna: 7 M $ al 30/04/2024
Cargos activos de Yekaterina Chudnovsky
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ELICIO THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/10/2022 | - |
| Independent Dir/Board Member | 01/10/2022 | - | |
| IMMIX BIOPHARMA, INC. | Director/Miembro de la Junta | 22/08/2023 | - |
| Independent Dir/Board Member | 22/08/2023 | - | |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Director/Miembro de la Junta | - | - |
xCures, Inc.
 xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Director/Miembro de la Junta | - | - |
| Gkcc LLC | Director/Miembro de la Junta | - | - |
Historial de carrera de Yekaterina Chudnovsky
Formación de Yekaterina Chudnovsky.
| Northwestern University | Undergraduate Degree |
| DePaul University | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 8 |
Operativa
| Director/Board Member | 5 |
| Independent Dir/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
| Technology Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| IMMIX BIOPHARMA, INC. | Health Technology |
| ELICIO THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
xCures, Inc.
xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Technology Services |
| Gkcc LLC |